rs162036

Positions:

chr5-7885846-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002454.3(MTRR):c.1049A>G(p.Lys350Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 1,613,752 control chromosomes in the GnomAD database, including 20,669 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4532 hom., cov: 31)

Exomes 𝑓: 0.13 ( 16137 hom. )

Consequence

MTRR
NM_002454.3 missense

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:7

Conservation

PhyloP100: 1.22

Variant links:

Genes affected

MTRR (HGNC:7473): (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]

MTRR links:

MTRR (HGNC:):

MTRR links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.0026747882).

BP6

Variant 5-7885846-A-G is Benign according to our data. Variant chr5-7885846-A-G is described in ClinVar as [Benign]. Clinvar id is 138291.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-7885846-A-G is described in Lovd as [Benign].

BA1

GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.376 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
MTRR	NM_002454.3 linkuse as main transcript	c.1049A>G	p.Lys350Arg	missense_variant	7/15	ENST00000440940.7	NP_002445.2	Q9UBK8-2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
MTRR	ENST00000440940.7 linkuse as main transcript	c.1049A>G	p.Lys350Arg	missense_variant	7/15	1	NM_002454.3	ENSP00000402510.2		Q9UBK8-2

Frequencies

GnomAD3 genomes

AF:

0.206

AC:

31298

AN:

151904

Hom.:

4518

Cov.:

show subpopulations

Gnomad AFR

AF:

0.381

Gnomad AMI

AF:

0.0384

Gnomad AMR

AF:

0.295

Gnomad ASJ

AF:

0.175

Gnomad EAS

AF:

0.173

Gnomad SAS

AF:

0.142

Gnomad FIN

AF:

0.0682

Gnomad MID

AF:

0.177

Gnomad NFE

AF:

0.112

Gnomad OTH

AF:

0.198

GnomAD3 exomes

AF:

0.176

AC:

44240

AN:

251438

Hom.:

5490

AF XY:

0.163

AC XY:

22129

AN XY:

135900

show subpopulations

Gnomad AFR exome

AF:

0.394

Gnomad AMR exome

AF:

0.367

Gnomad ASJ exome

AF:

0.171

Gnomad EAS exome

AF:

0.183

Gnomad SAS exome

AF:

0.146

Gnomad FIN exome

AF:

0.0752

Gnomad NFE exome

AF:

0.115

Gnomad OTH exome

AF:

0.141

GnomAD4 exome

AF:

0.133

AC:

193961

AN:

1461728

Hom.:

16137

Cov.:

AF XY:

0.131

AC XY:

95378

AN XY:

727168

show subpopulations

Gnomad4 AFR exome

AF:

0.393

Gnomad4 AMR exome

AF:

0.357

Gnomad4 ASJ exome

AF:

0.175

Gnomad4 EAS exome

AF:

0.166

Gnomad4 SAS exome

AF:

0.145

Gnomad4 FIN exome

AF:

0.0740

Gnomad4 NFE exome

AF:

0.115

Gnomad4 OTH exome

AF:

0.149

GnomAD4 genome

AF:

0.206

AC:

31363

AN:

152024

Hom.:

4532

Cov.:

AF XY:

0.204

AC XY:

15165

AN XY:

74302

show subpopulations

Gnomad4 AFR

AF:

0.381

Gnomad4 AMR

AF:

0.296

Gnomad4 ASJ

AF:

0.175

Gnomad4 EAS

AF:

0.173

Gnomad4 SAS

AF:

0.142

Gnomad4 FIN

AF:

0.0682

Gnomad4 NFE

AF:

0.112

Gnomad4 OTH

AF:

0.200

Alfa

AF:

0.137

Hom.:

3669

Bravo

AF:

0.233

TwinsUK

AF:

0.118

AC:

438

ALSPAC

AF:

0.115

AC:

443

ESP6500AA

AF:

0.377

AC:

1662

ESP6500EA

AF:

0.118

AC:

1019

ExAC

AF:

0.171

AC:

20761

Asia WGS

AF:

0.158

AC:

553

AN:

3478

EpiCase

AF:

0.121

EpiControl

AF:

0.124

ClinVar

Significance: Benign

Submissions summary: Uncertain:1Benign:7

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Methylcobalamin deficiency type cblE

Benign:4

Benign, criteria provided, single submitter	clinical testing	Pars Genome Lab	Jun 19, 2021	- -
Benign, no assertion criteria provided	clinical testing	Natera, Inc.	Sep 16, 2020	- -
Benign, criteria provided, single submitter	clinical testing	Genome-Nilou Lab	Sep 05, 2021	- -
Benign, criteria provided, single submitter	clinical testing	Labcorp Genetics (formerly Invitae), Labcorp	Feb 01, 2024	- -

Gastrointestinal stromal tumor

Uncertain:1

Uncertain significance, no assertion criteria provided

case-control

Department of Pharmacy and Biotechnology, University of Bologna

- -

not specified

Benign:1

Benign, criteria provided, single submitter

clinical testing

GeneDx

May 29, 2013

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Disorders of Intracellular Cobalamin Metabolism

Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jan 12, 2018

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided

Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.067

BayesDel_addAF

Benign

-0.62

BayesDel_noAF

Benign

-0.52

CADD

Benign

6.5

DANN

Benign

0.97

Eigen

Benign

-0.71

Eigen_PC

Benign

-0.74

FATHMM_MKL

Uncertain

0.81

LIST_S2

Benign

0.73

T;T

MetaRNN

Benign

0.0027

T;T

MetaSVM

Benign

-0.94

MutationAssessor

Benign

1.3

L;.

PrimateAI

Benign

0.29

PROVEAN

Benign

-2.0

N;N

REVEL

Benign

0.11

Sift

Benign

0.24

T;T

Sift4G

Benign

0.14

T;T

Vest4

0.024

MPC

0.050

ClinPred

0.0093

GERP RS

-2.2

Varity_R

0.099

gMVP

0.35

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over